In the BioHarmony Drug Report Database

"Preview" Icon

Sugammadex

Bridion (sugammadex) is an oligosaccharide pharmaceutical. Sugammadex was first approved as Bridion on 2008-07-25. It has been approved in Europe to treat neuromuscular blockade. Bridion’s patents are valid until 2026-01-27 (FDA).

 

Trade Name

 

Bridion
 

Common Name

 

sugammadex
 

ChEMBL ID

 

CHEMBL2111107
 

Indication

 

neuromuscular blockade
 

Drug Class

 

Image (chem structure or protein)

Sugammadex structure rendering